Health P.E.I. CEO says streamlined executive team will boost accountability, performance
Health P.E.I. says it's making changes to its executive leadership team in what it calls an important step in restoring public trust.
The main changes include the addition of the following positions: chief of governance and risk, chief of people and professional practice, and provincial chief of nursing.
"The health-care system is fairly large and complex here in Prince Edward Island, and it really needs to be well-managed," Health P.E.I. CEO Melanie Fraser said in an interview with CBC News.
"We've streamlined the number of executives but we've put a real focus on accountability and performance."
The changes come after the provincial health agency received audit recommendations on restructuring its executive leadership team, which currently has many senior roles being filled on an interim basis using contract employees hired through private recruitment agencies.
Filling new positions
Fraser said Health P.E.I. has started recruiting for the new executive leadership positions in an open and transparent process, adding that anybody who wants to compete for one of the positions is welcome to do so.
The salaries of the executive positions were approved by Health P.E.I.'s board of directors and will be made public, she said.
"In setting these salaries, we identified our Atlantic comparators and we sought to compare our salaries to theirs," Fraser said.
"We didn't want to lead or lag the market. We wanted to be in a place where we could recruit and retain, but still be fiscally responsible and recognize that we are a small health authority relative to some of our… comparators."
We need an executive that is built [for] and capable of delivering the highest quality care, delivering value care and ensuring that the services are here for Islanders. — Health P.E.I. CEO Melanie Fraser
While Fraser said reducing the cost of the new executive leadership structure wasn't one of the guiding principles, she said it will be more cost-effective than what has been done in the past.
Fraser said the last executive structure that was in place in 2024 cost about $2 million when fully staffed, while salaries for this new one are set to add up to between $1 million and $1.5 million.
Effect on everyday Islanders
While average Islanders might not notice much of a difference when it comes to executive leadership changes within the provincial health authority, Fraser said the trickle-down effects will improve the care they get.
"We need an executive that is built [for] and capable of delivering the highest quality care, delivering value care and ensuring that the services are here for Islanders," she said.
"Over the course of the past year, we have — with our interim executive — been able to drive results that are quite significant relative to what we were seeing over the course of the past couple of years."
Fraser said MRI and diagnostic imaging wait times have gone down, the number of open hospital beds has gone up and the surgical backlog has been reduced.
Health P.E.I. has also hired more staff across the province this year compared to any previous year, Fraser said.
"It's about having the right process, the right procedures. It's a complex, very integrated system and we need to move it all forward," she said, adding that Health P.E.I. will continue to push hard to deliver better access and lower wait times.
"I won't be satisfied until we meet national standards or better."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Hershey to host ALS United Walk this weekend
(WHTM) — Tuesday's Hometown Heroes will walk with a purpose in Hershey this weekend. The Hershey ALS United Walk takes place Saturday, June 7, at 12 p.m. at the Hershey Middle School. Close Thanks for signing up! Watch for us in your inbox. Subscribe Now This year, ALS United Mid-Atlantic hopes to raise $150,000 as part of its mission to ensure every person with ALS has access to support. Goodwill in Dauphin County announces grand opening of new location Those interested in the event can register in advance online or in person at the event. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Health Line
2 hours ago
- Health Line
Does Osteoporosis Affect Your Teeth?
Teeth are not bones, so they are not directly affected by osteoporosis. However, osteoporosis can lead to jaw damage, which in turn can cause serious dental problems. Osteoporosis is a bone disease resulting in the loss of bone mass and density. It can lead to weak bones, which increases the risk of fractures. Like many people with osteoporosis, you may wonder if it will affect your teeth. The short answer is: not directly. Since your teeth aren't actually bones, osteoporosis itself doesn't change your teeth's health or composition. Yet osteoporosis can have an indirect effect on your teeth. This is because it can cause changes to your jaw, which can affect how your teeth are held in place. In fact, osteoporosis has been associated with an increased likelihood of tooth loss for this reason. It's important to not only brush your teeth but also brush up on information about how osteoporosis may affect your oral health. We'll review what to know about how teeth and bones differ, current research on how osteoporosis affects teeth, and how treatment works. What are teeth made of? Although they do have some characteristics in common, your teeth and your bones are not made of the exact same materials. Your bones are mostly collagen and the mineral calcium phosphate. Teeth, on the other hand, consist of the following main layers: Enamel is the hard calcified tissue on the top (crown) of teeth that isn't made of living cells. Cementum is another type of hard tissue that protects a tooth's root. Dentin is below enamel and cementum, making up most of our teeth's interior and providing structure. Pulp is the innermost layer of our teeth and contains nerves and blood vessels. Osteoporosis damages your bones' ability to produce new tissue to make up their spongy interior. People may mistake teeth for bones because the whitish enamel covering the crown of your teeth looks like bone. But unlike our bones, enamel isn't made of living tissue. Research findings The link between osteoporosis and tooth loss is well-established and has been the subject of many scientific studies. These include: A study from 2017 also found that postmenopausal women in South India were more likely to experience tooth loss if they had developed osteoporosis. A 2024 systematic review concluded that osteoporosis is associated not only with loss of bone density in the jaw area but also with periodontal disease and tooth loss. A 2024 study showed that osteoporosis is associated with loss of bone in the alveolar process (the bone structure that holds the roots of your teeth in place), leading to tooth loss. Another 2024 study of postmenopausal women saw an association between vertebral fractures and tooth loss. Researchers are pretty clear that osteoporosis and tooth loss are connected, but they are still investigating the exact nature of that connection. A key theory for the link is that as osteoporosis progresses, your jawbone also weakens and loses some of its density. When the jawbone weakens, teeth begin to lose some of their stability. These jawbone changes may affect tooth alignment, damaging their roots and causing oral health complications. Osteoporosis medications and teeth If you take medication for osteoporosis, be sure to talk with your doctor about its possible effects on your teeth. Be aware that medications that strengthen bones can sometimes cause damage to your jawbone. The treatment most commonly prescribed for people with osteoporosis is bisphosphonate therapy. Bisphosphonates, which can be administered orally (by mouth) or intravenously (through a vein), can help strengthen your bones and ward off future fractures. Many people also take calcium or vitamin D with bisphosphonates, according to the American College of Rheumatology. But there's a risk to your jaw and teeth when you take bisphosphonates. This type of treatment has been linked to the development of a rare degenerative complication called osteonecrosis of the jaw (ONJ). According to the Endocrine Society, the risk of developing ONJ is highest after dental surgery. It tends to occur more frequently in people who have undergone 'high dose, long-term therapy, as might be given during cancer treatment.' Keeping bones and teeth healthy One of the most important things you can do is prioritize the health of your bones and teeth by maintaining habits that contribute to their overall well-being. Some key factors include: eating a b alanced diet making sure you get 800 to 1000 IU of vitamin D each day aiming for 1,000 to 1,200 milligrams of calcium each day not smoking, or considering quitting smoking if you currently smoke limiting your consumption of alcohol being physically active — the World Health Organization (WHO) has exercise guidelines by age group If you're having trouble getting enough calcium or vitamin D from the foods that you eat, talk with your doctor or a nutritionist about taking a supplement. Make sure you always take supplements as directed. Proper dental hygiene is essential for the long-term health of your teeth. The American Dental Association (ADA) recommends the following: Brush your teeth thoroughly twice a day for 2 minutes per session. Use toothpaste containing fluoride when brushing your teeth. Clean between your teeth daily (including flossing, interdental brushes, and others). Limit your intake of sugary beverages and snacks. Aim to visit your dentist for regular checkups. Let your dentist know if you're taking an antiresorptive agent, like a bisphosphonate, so they can accommodate it in your treatment plan — especially if you'll be undergoing any surgical procedures like a tooth extraction. You likely won't need to stop taking your osteoporosis treatment or skip the procedure, according to the ADA, but your dentist may need to make some accommodations. Know your risk Prioritizing and monitoring oral health can be especially important if you have existing dental health concerns or if you have certain risk factors for osteoporosis. Your chances of developing osteoporosis increase as you get older. Women tend to be at elevated risk, and the loss of estrogen that occurs with menopause can also contribute. Treating osteoporosis Currently, there's no cure for osteoporosis, so prevention remains the best strategy. However, there are several osteoporosis management and treatment options, according to 2018 research. Certain drugs for osteoporosis aim to prevent bone loss (antiresorptive medications), while others seek to regrow bone (anabolic medications). Both classes of drugs aim to increase bone density and lower your chance of fractures. Depending on your specific needs and health, your doctor might advise taking the following: Bisphosphonate medications. These are usually the first medications prescribed for postmenopausal women, and they work by slowing the breakdown of bone. Selective estrogen receptor modulators (SERMs), also known as estrogen agonists, are a class of medications that also treat osteoporosis in women and other conditions like breast cancer. Most commonly, SERMS, raloxifene, is used to treat these conditions. Hormone replacement therapy. These drugs are synthetic versions of our naturally occurring hormones. Since loss of estrogen due to menopause can contribute to osteoporosis, estrogen therapy can help, although it's often not the first-line treatment. Testosterone therapy is sometimes used similarly for osteoporosis in men. Calcitonin. This is a synthetic version of a hormone your thyroid gland produces that regulates calcium. It comes in a nasal spray and is approved by the Food and Drug Administration (FDA) for treating osteoporosis in certain postmenopausal women. Antibody medications. Also called biologics, these can slow the breakdown of bone and encourage new bone formation. The two available drugs are denosumab and romosozumab, both administered through injections. Parathyroid hormone therapies. Parathyroid hormones (PTHs) increase bone density and strength, helping prevent fractures. The PTH injectable medications teriparatide and abaloparatide are both FDA-approved to treat osteoporosis. Calcium and vitamin D supplements. These are essential for building and maintaining strong bones (and teeth). Physical therapy (PT) is also often used to treat osteoporosis and aims to strengthen muscle and bone to prevent future fractures (or recover from fractures). A PT exercise regimen will be tailored specifically to your health needs. It can be done in a few minutes per day at home or at regular sessions with your physical therapist. Takeaway Teeth are not bones, so they aren't directly affected by osteoporosis. However, osteoporosis can affect your teeth indirectly by causing changes or damage to your jawbone. Maintaining healthy habits promotes bone and oral health in the long term. This includes not smoking, eating a balanced diet, exercising regularly, and practicing proper dental hygiene.
Health Line
2 hours ago
- Health Line
Does Medicare Cover BCG Treatment for Bladder Cancer?
BCG is an immunotherapy treatment. Medicare may cover BCG when medically necessary to treat certain types of bladder cancer or after a transurethral resection of bladder tumor (TURBT). Bacillus Calmette-Guerin (BCG) is the standard immunotherapy drug for bladder cancer. Immunotherapy uses your own immune system to attack cancer cells. With BCG, the doctor inserts a catheter into your bladder to deposit a drug made from a weakened strain of Mycobacterium bovis, a vaccine for tuberculosis. Original Medicare (parts A and B) covers approved treatments and services for bladder cancer that your healthcare team deems medically necessary, which can include BCG. Read on to learn about when Medicare might cover BCG, your eligibility for coverage, and your anticipated costs. Are you eligible for BCG treatment for bladder cancer with Medicare? Doctors tend to recommend BCG treatment for carcinoma in situ and non-muscle invasive bladder cancer, which includes noninvasive (stage 0) and minimally invasive (stage 1) bladder cancers. They also typically would suggest it after you've received a procedure known as transurethral resection of bladder tumor (TURBT) to reduce your chance of the cancer returning. Generally, Original Medicare should approve BCG if you need it under these circumstances. Part A will cover it while you're hospitalized, whereas Part B will cover it if you get the treatment as an outpatient. If you're enrolled in Medicare Advantage (Part C), you should receive the same coverage. Is Anktiva covered by Medicare? The U.S. Food and Drug Administration (FDA) has approved the drug Anktiva for use alongside BCG treatment. Like BCG, Anktiva is administered into the bladder. Medicare Part A and B may cover Anktiva if medically necessary, with covered BCG treatment. Note that Parts A and B should cover the drug itself and not just the catheter administration procedure. This is because you cannot administer the medication to yourself, in which case it would fall under the coverage of Medicare Part D. That said, currently there is a shortage of the BCG drug. For this reason, according to the Centers for Medicare & Medicaid Services (CMS), Medicare may approve your treatment at a dose less than the usual dose of 81 milligrams (mg) or 1 vial per session. How much does BCG treatment for bladder cancer cost? A 2021 study analyzed the administration of BCG therapy within the Veterans Affairs Health System between 2000 and 2015. After one year, the median cost was around $29,459, increasing to $55,267 by two years, and reaching $117,361 at five years. That said, your share of this cost after your Medicare coverage kicks in depends on the part of Medicare responsible for your coverage. Under Part B, after you've met the 2025 deductible of $257, Part B will pay for 80% of any covered treatment or service. You also have to pay a monthly premium, which starts at $185, depending on your income. Under Part A, in most cases, you don't have a premium, though you must meet a $1,676 deductible. Once you do, Part A will cover your treatment fully for the first 60 days of hospitalization. After that, you begin to incur a daily cost that increases over time until you become responsible for the full, remaining cost. If you're covered by Part C, your plan is managed by a private insurer, which means your premium, deductible, and coinsurance depend on your plan. According to the Centers for Medicaid & Medicare (CMS), the average monthly premium for Part C plans is around $17.00 in 2025. In addition, to remain enrolled in a Part C plan, you still have to pay the Part B premium. That said, some Part C may cover your Part B premium. Where can you get help with the cost of BCG treatment for bladder cancer? Several factors affect the cost of treating bladder cancer, including: how aggressive the cancer is the stage at which it was diagnosed the treatment prescribed by your doctor Managing your medical expenses starts with ensuring that your doctor accepts your Original Medicare or Part C plan. If you're enrolled in Original Medicare, you can also consider enrolling in a Medicare supplement plan (Medigap) to help with out-of-pocket costs, such as copayments and deductibles. You can choose from 10 different plans, depending on factors like your location and coverage needs. However, you cannot use Medigap with Medicare Advantage (Part C) plans. You may also wish to check if you qualify for a Medicare Savings Program (MSP) and Extra Help, and if you might dually qualify for Medicare and Medicaid. Outside of Medicare, you may wish to check non-profit financial assistance programs. What other treatments does Medicare cover for bladder cancer? Medicare Part A covers inpatient hospital stays, including cancer treatments and diagnostics you receive as an inpatient. Part A also offers: some coverage for care at home, such as skilled nursing and physical therapy limited coverage for care in a skilled nursing facility after 3 days in the hospital care in a hospice In the case of medically necessary outpatient treatments and services to treat bladder cancer, Medicare Part B covers: visits with your doctor (including oncologists and other specialists) diagnostic testing (lab tests, ultrasound, etc.) many chemotherapy drugs administered through an IV at your doctor's office or a clinic some chemotherapy drugs administered orally outpatient clinic radiation treatments durable medical equipment, such as feeder pumps and wheelchairs Any treatment drugs you can take yourself would fall under Part D coverage. That said, Medicare may not cover every medication. Always confirm coverage and expected costs before receiving treatment. If Medicare doesn't cover the treatment you need, discuss payment plans or other options with your doctor. Takeaway Medicare covers treatment and services for bladder cancer; however, you may still have significant out-of-pocket costs depending on factors like recommended treatment or the stage of your cancer. You can work with your doctor to develop a treatment plan that maximizes your Medicare coverage. If you have additional coverage, such as a Medicare Part D (prescription drug) plan or a Medigap (Medicare supplement) plan, many of your out-of-pocket costs will be covered.
